You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CXCR4 inhibition

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Aldosterone-Producing Adenoma Trial (CXCR4)

Not yet recruiting
  • Aldosterone-Producing Adenoma
  • CXCR4
  • (no location specified)
Apr 20, 2023

Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)

Recruiting
  • Vasculitis
  • Diagnoses Disease
  • CXCR4-PET
  • Würzburg, Bayern, Germany
    Departement of Internal Medicine II, Rheumatology/Clinical Immun
Dec 4, 2022

Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

Completed
Has Results
  • Hiv
  • Autologous CD4 T-Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 13, 2022

Tumor Malignant Trial in Napoli (CLG)

Active, not recruiting
  • Neoplasm Malignant
  • CLG
  • Napoli, Italy
  • +1 more
Apr 18, 2023

CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

Not yet recruiting
  • CXCR4
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Feb 15, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

Recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • CXCR4 Antagonist BL-8040
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Seborrheic Dermatitis, Papulopustular Rosacea Trial in New York (PF-07038124, Placebo Ointment)

Recruiting
  • Seborrheic Dermatitis
  • Papulopustular Rosacea
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 22, 2023

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with

Recruiting
  • Inhibition of Autophagy Synergizes Anti-tumor Effect
  • 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
  • RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023

Re-EValuating Inhibition of Stress Erosions - COVID-19 Cohort

Recruiting
  • COVID-19
  • GastroIntestinal Bleeding
  • Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial (NCT03374800)
  • Hamilton, Ontario, Canada
    St Joseph's Healthcare Hamilton
Feb 6, 2023

Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Stanford, California
  • +3 more
Jan 10, 2023

Multiple Myeloma Trial (CXCR4 modified anti-BCMA CAR T cells)

Not yet recruiting
  • Multiple Myeloma
  • CXCR4 modified anti-BCMA CAR T cells
  • (no location specified)
Apr 7, 2021

COVID-19 Trial in Brandenburg an der Havel (Palbociclib)

Withdrawn
  • COVID-19
  • Brandenburg an der Havel, Germany
    Universitätsklinikum Brandenburg an der Havel
Nov 3, 2022

Nasal Polyps, Asthma, Aspirin-Induced, Aspirin-Exacerbated Respiratory Disease Trial in Boston (Dupilumab, Placebo)

Not yet recruiting
  • Nasal Polyps
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 7, 2022

Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Hypertension
  • Placebo
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University
Feb 8, 2022

Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

Recruiting
  • Lymphoma
  • +2 more
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021

Asthma Trial in Ann Arbor (Dupilumab)

Recruiting
  • Asthma
  • Ann Arbor, Michigan
    University of Michigan
Mar 3, 2022

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)

Recruiting
  • Recurrent Glioblastoma
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 20, 2022